← Eichor
Condition: Urothelial Carcinoma Uc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Urothelial Carcinoma Uc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06982794Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bl
Phase N/A · 23 location(s) · Convergent Genomics, Inc. · NCT07673016Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Phase N/A · 1 location(s) · Samsung Medical Center · NCT07452432Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Phase 2 · 1 location(s) · University of California, Irvine · NCT06682728Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
Phase 1 · 122 location(s) · Exelixis · NCT05176483DK222 Study at Hopkins
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07140315Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
EARLY_Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07439120A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT0727741318F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NA · 1 location(s) · Peking University First Hospital · NCT07557225Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
Phase N/A · 1 location(s) · Henan Provincial People's Hospital · NCT07614594A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Phase 1 · 7 location(s) · Shanghai Henlius Biotech · NCT07518043Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Phase N/A · 1 location(s) · Tianjin Medical University Second Hospital · NCT07441499A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · 10 location(s) · ITM Oncologics GmbH · NCT05706129Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Phase N/A · 1 location(s) · Oslo University Hospital · NCT07602010Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients
NA · 1 location(s) · Istituto Clinico Humanitas · NCT07413523
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.